Metaxalone Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-R-0001

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents4
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation, identified as SPE2D2-26-R-0001, for the procurement of Metaxalone Tablets. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and carries the Product Service Code 6505, indicating a focus on medical and pharmaceutical products. The primary objective of this procurement is to secure a reliable supply of Metaxalone Tablets, a muscle relaxant commonly used in medical treatment. The scope of the solicitation encompasses the manufacturing and delivery of these pharmaceutical products in accordance with federal standards and requirements. Contractors are expected to provide Metaxalone Tablets that meet all applicable regulatory and quality specifications, ensuring the safety and efficacy of the medication for end users within the federal system. DLA Troop Support, a federal office, serves as the contracting entity for this solicitation. Interested parties should note that the solicitation has been amended (Amendment 0003), and all relevant documentation is available via the provided SAM.gov opportunity link. The procurement is currently active, with a response deadline set for January 5, 2026, at 20:01. The solicitation was posted on December 22, 2025. Key requirements for this opportunity include compliance with pharmaceutical manufacturing standards as defined by the NAICS code, adherence to federal acquisition regulations, and the ability to deliver the specified product within the required timeframe. While the notice does not specify set-aside requirements or special considerations, contractors should review the attached solicitation and amendments for detailed instructions, evaluation criteria, and submission guidelines. For further information or clarification, contractors may contact Jeremy Brown ([email protected], 445-737-5419) as the primary point of contact, or Jason Wray ([email protected], 445-737-6304) as the secondary contact. This procurement represents a significant opportunity for qualified pharmaceutical manufacturers to support federal medical supply chains. Interested contractors are encouraged to review all solicitation materials and amendments to ensure their capabilities align with the stated requirements and to prepare a comprehensive response by the specified deadline.